Tag: Small Pharma - Psychedelic Alpha

Access exclusive insights, data and interviews with Pα+: learn more and subscribe today.

Read more about the article Disposition of Common Shares of Small Pharma Inc.

Disposition of Common Shares of Small Pharma Inc.

Post published:October 3, 2023
Post category:Press Release

Read more about the article Small Pharma Reports Positive Top-line Data from SPL026 (DMT)-SSRI Drug Interaction Study in Patients with Major Depressive Disorder

Small Pharma Reports Positive Top-line Data from SPL026 (DMT)-SSRI Drug Interaction Study in Patients with Major Depressive Disorder

Post published:September 26, 2023
Post category:Press Release

Read more about the article Cybin Set to Acquire British DMT Drug Developer Small Pharma

Cybin Set to Acquire British DMT Drug Developer Small Pharma

Post published:August 28, 2023
Post category:News

Read more about the article Small Pharma Reports Fiscal First Quarter 2024 Highlights

Small Pharma Reports Fiscal First Quarter 2024 Highlights

Post published:July 28, 2023
Post category:Press Release

Read more about the article Small Pharma Announces SPL028 R&D Strategy Update

Small Pharma Announces SPL028 R&D Strategy Update

Post published:July 5, 2023
Post category:Press Release

Read more about the article Small Pharma Reports Financial Results for the Fiscal Year Ended February 28, 2023 and Recent Business Highlights

Small Pharma Reports Financial Results for the Fiscal Year Ended February 28, 2023 and Recent Business Highlights

Post published:June 28, 2023
Post category:Press Release

Read more about the article Small Pharma Announces Significant Developments In Intellectual Property Portfolio

Small Pharma Announces Significant Developments In Intellectual Property Portfolio

Post published:May 25, 2023
Post category:Press Release

Read more about the article Small Pharma to Present at Upcoming CINP World Congress of Neuropsychopharmacology

Small Pharma to Present at Upcoming CINP World Congress of Neuropsychopharmacology

Post published:May 3, 2023
Post category:Press Release

Read more about the article Small Pharma Announces Positive Six-month Data from Phase IIa Trial of SPL026

Small Pharma Announces Positive Six-month Data from Phase IIa Trial of SPL026

Post published:April 4, 2023
Post category:Press Release

Read more about the article Small Pharma to Host Virtual Roundtable Event with Key Opinion Leaders in Psychiatry

Small Pharma to Host Virtual Roundtable Event with Key Opinion Leaders in Psychiatry

Post published:March 7, 2023
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.